MMP9 and neoplasm: Although this cluster relationship was not correlated to the tumor clinical stages, previous studies showed the same phenotypic progress with the low level of MMP9 (20q13.12) activity in the potential of HN31 and HN4 invasion, but not for HN30 and HN12 [16, 50].